The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

This study investigated patients with primary lung cancer who received PET/CT scan, a medical imaging test, and subsequently ...

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious ...

In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

Addition of the immunotherapy drug pembrolizumab to standard of care ... Duke University and Princess Margaret Cancer Centre, ...

The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...